To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Commons Chamber
Spice-spiked Vapes - Tue 15 Oct 2024
Home Office

Mentions:
1: Wera Hobhouse (LD - Bath) contained Spice, while one in 100 contained tetrahydrocannabinol or THC, the psychoactive component of cannabis - Speech Link
2: Diana Johnson (Lab - Kingston upon Hull North and Cottingham) suggestion of a link in the term “synthetic cannabinoid”, there is no relationship between SCRAs and the cannabis - Speech Link
3: Diana Johnson (Lab - Kingston upon Hull North and Cottingham) It explains that SCRAs can be more potent than cannabis and that the effects may last for life. - Speech Link

Non-Departmental Publication (Transparency)
Security Industry Authority

Jan. 25 2024

Source Page: SIA licence-linked training relating to medical cannabis
Document: SIA licence-linked training relating to medical cannabis (webpage)

Found: SIA licence-linked training relating to medical cannabis

Written Question
Epilepsy: Cannabis
Wednesday 21st February 2024

Asked by: Sarah Dyke (Liberal Democrat - Glastonbury and Somerton)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when she expects the randomised controlled trials to test medicinal cannabis for adults and children with epilepsy to begin; which NHS Trusts will be participating in these trials; how many patients will be involved in the trials; and whether patients will be approached to participate.

Answered by Andrew Stephenson

The Department, via the National Institute for Health and Care Research, is developing a programme of two randomised controlled trials to test the safety and efficacy of medicinal cannabis products to treat epilepsy in adults and children. The trials will start as soon as possible, and results will be published once the trials have been completed and the findings peer reviewed. The trial details are in development.

Written Question
Cannabis: Medical Treatments
Wednesday 21st February 2024

Asked by: Paula Barker (Labour - Liverpool Wavertree)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what plans her Department has to make medicinal cannabis more accessible to those who need it.

Answered by Andrew Stephenson

Licensed cannabis-based medicines are routinely available on the National Health Service. However, clinical guidelines from the National Institute for Health and Care Excellence (NICE) demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based medicines.

The Government continues to call on manufacturers to invest in research and clinical trials to prove if their products are safe and effective and offers scientific and research advice from the Medicines and Healthcare products Regulatory Agency and the NICE.

Written Question
Cannabis: Medical Treatments
Tuesday 27th February 2024

Asked by: Jim Shannon (Democratic Unionist Party - Strangford)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many people aged under 18 have been prescribed medicinal cannabis as of 19 February 2024.

Answered by Andrew Stephenson

The Department does not hold details relating to the age of people prescribed medicinal cannabis.

Departmental Publication (News and Communications)
Department for Environment, Food and Rural Affairs

Nov. 06 2024

Source Page: Hemp licence burdens to be cut back to help grow UK economy
Document: Hemp licence burdens to be cut back to help grow UK economy (webpage)

Found: “Hemp” is a variety of cannabis with “low-THC” levels, which is currently defined as a maximum of 0.2%

Scottish Cross Party Group Publication (Annual return / report)
Source Page: Cross-Party Group in the Scottish Parliament on Medicinal Cannabis
Document: Annual Return Form 2022 to 2023 (PDF)

Found: Cross -Party Group Annual Return Name of Cross -Party Group Cross -Party Group Medicinal Cannabis

Written Question
Bermuda: Cannabis
Tuesday 5th March 2024

Asked by: Andrew Rosindell (Conservative - Romford)

Question to the Foreign, Commonwealth & Development Office:

To ask the Minister of State, Foreign, Commonwealth and Development Office, whether he has had recent discussions with his counterpart in Bermuda on the decriminalisation of possession of cannabis in that territory.

Answered by David Rutley

The UK is committed to working in partnership with Bermuda and we remain available to discuss new proposals on this legislation, to find a way forward that works for Bermuda whilst also remaining within the scope of existing international obligations.

Select Committee
Action on Smoking and Health
 PHS0625 - Prevention in health and social care

Written Evidence Apr. 19 2024

Inquiry: Prevention in health and social care
Inquiry Status: Closed
Committee: Health and Social Care Committee (Department: Department of Health and Social Care)

Found: The more frequently people smoke cannabis and the longer they have smoked cannabis for the greater

Deposited Papers

Dec. 06 2011

Source Page: Statistics from the National Drug Treatment Monitoring System: 1 April 2010 - 31 March 2011. 30 p.
Document: DEP2011-1990.pdf (PDF)

Found: Cannabis was the primary drug for 7% of clients , powder cocaine for 5% of clients and crack